Extracellular Loops 2 and 4 of GLYT2 Are Required for N-arachidonylglycine Inhibition of Glycine Transport

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Oct 31

PMID 19875446

Citations 13

Authors

Amelia R Edington

Audra A McKinzie

Aaron J Reynolds

Michael Kassiou

Renae M Ryan

Robert J Vandenberg

Affiliations

Soon will be listed here.

Abstract

Concentrations of extracellular glycine in the central nervous system are regulated by Na(+)/Cl(-)-dependent glycine transporters, GLYT1 and GLYT2. N-Arachidonylglycine (NAGly) is an endogenous inhibitor of GLYT2 with little or no effect on GLYT1 and is analgesic in rat models of neuropathic and inflammatory pain. Understanding the molecular basis of NAGly interactions with GLYT2 may allow for the development of novel therapeutics. In this study, chimeric transporters were used to determine the structural basis for differences in NAGly sensitivity between GLYT1 and GLYT2 and also the actions of a series of related N-arachidonyl amino acids. Extracellular loops 2 and 4 of GLYT2 are important in the selective inhibition of GLYT2 by NAGly and by the related compounds N-arachidonyl-gamma-aminobutyric acid and N-arachidonyl-d-alanine, whereas only the extracellular loop 4 of GLYT2 is required for N-arachidonyl-l-alanine inhibition of transport. These observations suggest that the structure of the head group of these compounds is important in determining how they interact with extracellular loops 2 and 4 of GLYT2. Site-directed mutagenesis of GLYT2 EL4 residues was used to identify the key residues Arg(531), Lys(532), and Ile(545) that contribute to the differences in NAGly sensitivity.

Citing Articles

Glycine Transporter 2: Mechanism and Allosteric Modulation.

Frangos Z, Cantwell Chater R, Vandenberg R Front Mol Biosci. 2021; 8:734427.

PMID: 34805268 PMC: 8602798. DOI: 10.3389/fmolb.2021.734427.

Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Fairweather S, Shah N, Brer S Adv Exp Med Biol. 2020; 21:13-127.

PMID: 33052588 DOI: 10.1007/5584_2020_584.

MS Binding Assays for Glycine Transporter 2 (GlyT2) Employing Org25543 as Reporter Ligand.

Ackermann T, Allmendinger L, Hofner G, Wanner K ChemMedChem. 2020; 16(1):199-215.

PMID: 32734692 PMC: 7821181. DOI: 10.1002/cmdc.202000342.

Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies.

Zafra F, Ibanez I, Gimenez C Neuronal Signal. 2020; 1(1):NS20160009.

PMID: 32714574 PMC: 7377260. DOI: 10.1042/NS20160009.

Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics.

Mostyn S, Wilson K, Schumann-Gillett A, Frangos Z, Shimmon S, Rawling T Elife. 2019; 8.

PMID: 31621581 PMC: 6797481. DOI: 10.7554/eLife.47150.

References

Singh S, Yamashita A, Gouaux E . Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature. 2007; 448(7156):952-6. DOI: 10.1038/nature06038. View

Guastella J, Brecha N, Weigmann C, Lester H, Davidson N . Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc Natl Acad Sci U S A. 1992; 89(15):7189-93. PMC: 49671. DOI: 10.1073/pnas.89.15.7189. View

Gomeza J, Hulsmann S, Ohno K, Eulenburg V, Szoke K, Richter D . Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron. 2003; 40(4):785-96. DOI: 10.1016/s0896-6273(03)00672-x. View

Wiles A, Pearlman R, Rosvall M, Aubrey K, Vandenberg R . N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. J Neurochem. 2006; 99(3):781-6. DOI: 10.1111/j.1471-4159.2006.04107.x. View

Zhou Z, Zhen J, Karpowich N, Goetz R, Law C, Reith M . LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science. 2007; 317(5843):1390-3. PMC: 3711652. DOI: 10.1126/science.1147614. View

Arriza J, Fairman W, Wadiche J, Murdoch G, Kavanaugh M, Amara S . Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci. 1994; 14(9):5559-69. PMC: 6577102. View

Shevchuk N, Bryksin A, Nusinovich Y, Cabello F, Sutherland M, Ladisch S . Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously. Nucleic Acids Res. 2004; 32(2):e19. PMC: 373371. DOI: 10.1093/nar/gnh014. View

Vandenberg R, Mitrovic A, Johnston G . Serine-O-sulphate transport by the human glutamate transporter, EAAT2. Br J Pharmacol. 1998; 123(8):1593-600. PMC: 1565331. DOI: 10.1038/sj.bjp.0701776. View

Betz H, Gomeza J, Armsen W, Scholze P, Eulenburg V . Glycine transporters: essential regulators of synaptic transmission. Biochem Soc Trans. 2006; 34(Pt 1):55-8. DOI: 10.1042/BST0340055. View

10.

Bezuglov V, Bobrov M, Gretskaya N, Gonchar A, Zinchenko G, Melck D . Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine. Bioorg Med Chem Lett. 2001; 11(4):447-9. DOI: 10.1016/s0960-894x(00)00689-2. View

11.

Singh S, Piscitelli C, Yamashita A, Gouaux E . A competitive inhibitor traps LeuT in an open-to-out conformation. Science. 2008; 322(5908):1655-61. PMC: 2832577. DOI: 10.1126/science.1166777. View

12.

Yamashita A, Singh S, Kawate T, Jin Y, Gouaux E . Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature. 2005; 437(7056):215-23. DOI: 10.1038/nature03978. View

13.

Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter D . Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron. 2003; 40(4):797-806. DOI: 10.1016/s0896-6273(03)00673-1. View

14.

Liu Q, Lopez-Corcuera B, Mandiyan S, Nelson H, Nelson N . Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features. J Biol Chem. 1993; 268(30):22802-8. View

15.

Ju P, Aubrey K, Vandenberg R . Zn2+ inhibits glycine transport by glycine transporter subtype 1b. J Biol Chem. 2004; 279(22):22983-91. DOI: 10.1074/jbc.M312484200. View

16.

Vuong L, Mitchell V, Vaughan C . Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology. 2007; 54(1):189-93. DOI: 10.1016/j.neuropharm.2007.05.004. View

17.

Vandenberg R, Shaddick K, Ju P . Molecular basis for substrate discrimination by glycine transporters. J Biol Chem. 2007; 282(19):14447-53. DOI: 10.1074/jbc.M609158200. View

18.

Huang S, Bisogno T, Petros T, Chang S, Zavitsanos P, Zipkin R . Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem. 2001; 276(46):42639-44. DOI: 10.1074/jbc.M107351200. View

19.

Aprison M, WERMAN R . The distribution of glycine in cat spinal cord and roots. Life Sci. 1965; 4(21):2075-83. DOI: 10.1016/0024-3205(65)90325-5. View

20.

Morita K, Motoyama N, Kitayama T, Morioka N, Kifune K, Dohi T . Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. J Pharmacol Exp Ther. 2008; 326(2):633-45. DOI: 10.1124/jpet.108.136267. View